from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0117/oxyS

LFCtreatmentdescriptionclass of inhibitor

0.649

Amikacinug/mL Amikacintranslation

0.580

Cap5-10ug/mL Capreomycintranslation

3.318

Rox10-50 ug/mL Roxithromycintranslation

0.727

SM2-5 ug/mL Streptomycintranslation

0.682

Tet5-10 ug/mL Tetracyclinetranslation

0.248

Rif0.2-5ug/mL Rifampicintranscription

0.011

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.405

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.027

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.134

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.240

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.071

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.029

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.640

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.926

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.244

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.157

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.388

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.866

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.255

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.448

KCN5-20 ug/mL Potassium cyaniderespiration

1.645

NaN30.2-2 mM Sodium aziderespiration

-1.270

Nigericin50 uM Nigericinrespiration

-0.040

TRC10-150 ug/mL Triclosanrespiration

-0.885

TRZ10-25 ug/mL Thioridazinerespiration

-0.025

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.574

menadione6-10 ug/mL Menadionerespiration

-0.049

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.023

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.227

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.488

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.063

NRP_1Non-replicating persistence stage 1dosRassociated

1.730

Amp0.2mg/mL AmpicillincellWall

-0.191

Cephalexin20-100 ug/mL CephalexincellWall

-0.356

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.304

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.099

EMB10-20 ug/mL EthambutolcellWall

0.440

Eta12-40 ug/mL EthionamidecellWall

0.099

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.392

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.425

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.212

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.346

BZA0.12 mg/mL BenzamidearomaticAmides

0.223

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.253

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.579

H2O24 mM hydrogen peroxideDNAdamaging

0.203

Levo10 ug/mL LevofloxacinDNAdamaging

0.223

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.501

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.004

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.029

UVUV-irradiationDNAdamaging

-0.461

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.140

Antimycin12.5-50 ug/mL Antimycin A?

-0.528

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.096

PA_110-50 ug/mL Antitubercular compound PA-1?

0.273

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.732

PA8240.2-2 ug/mL PA-824?

-1.051

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.645

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.566

Verapamil50 uM Verapamil?

-0.219

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.767

methoxatin10-20 ug/mL Methoxatin?